The Committee on Budgets will travel to Latvia from 14 to 16 April 2025. The main objective of this mission is to earn more about the budgetary implications of enhancing the EU preparedness, focusing in particular on defence spending, in relation to recent geopolitical shifts. As conflicts not only materialise in conventional forms but also through hybrid threats, significant financial resources can be required not only as defence spending but also across various domains.
The BUDG Members participating are Giuseppe Lupo (head of the mission, S&D), Andrzej Halicki (EPP), Hélder Sousa Silva (EPP), Jean-Marc Germain (S&D), Nils Ušakovs (S&D), Julien Sanchez (PfE), Tobiasz Bocheński (ECR) and Alexander Jungluth (ESN).
Question for written answer E-001193/2025 to the Commission Rule 144 Nikolaos Anadiotis (NI)
Articles 87 and 112 of the United Nations Convention on the Law of the Sea (UNCLOS)[1] stipulate that the laying and maintenance of submarine cables in the high seas is an inalienable right of all states. Furthermore, Article 79 stipulates that states are also entitled to lay submarine cables on the continental shelf of another country (coastal state) and that this coastal state can regulate the procedure but not impede it.
However, according to recent reports, the Italian vessel Ievoli Relume, which had been conducting surveys for the Greece-Cyprus electricity interconnection (Great Sea Interconnector) project, was pressured into leaving the area despite the fact that it was operating in international waters and within the Greek continental shelf. This raises serious questions about what essentially amounts to the non-implementation of international law and the lack of freedom of Member States to develop strategic infrastructure projects without the interference of non-EU countries.
In view of the above, can the Commission answer the following:
1.What precise measures does it intend to take to ensure that Member States can freely exercise their rights within their continental shelf and in international waters, in accordance with international law?
2.Will there be an official EU response towards Türkiye given its threatening behaviour, with a view to protecting the interests of EU Member States?
Question for written answer E-001271/2025 to the Commission Rule 144 Damien Carême (The Left), Martin Schirdewan (The Left)
In connection with the ongoing trial of German anti-fascist activist Maja T. in Budapest, concerns have been raised about their pre-trial detention conditions, including the fact that they were held in solitary confinement for extended periods. Concerns have also been raised about the fact that they were shackled at the hands and feet and were led into the courtroom on a leash, accompanied by masked, armed officers. On 21 February 2025, the German Federal Foreign Office criticised the ‘strange presentation in court’ in a post on X[1] and pointed out ‘that the extradition of Maja T. to Hungary was unlawful’.
1.While recognising that detention matters are primarily the responsibility of Member States, what actions is the Commission taking to ensure Hungary’s compliance with EU standards regarding humane detention conditions and procedural rights?
2.Considering the Commission’s commitment to procedural rights, how does it assess the use of physical restraint during the trial in this case, and does the Commission consider this a potential breach of EU law, including Directive (EU) 2016/343?
3.Will the Commission take further steps to monitor both Hungary’s compliance with the 2022 recommendation on pre-trial detention and the transposition of Directive (EU) 2016/343, and will it consider launching infringement procedures if necessary?
During the 69th Commission on the Status of Women (CSW69), held from 10–21 March 2025, countries from around the world reaffirmed their commitment to gender equality through a high-level political declaration. The declaration renewed the global commitment to women’s rights, acknowledged the setbacks and called for urgent, gender-responsive policy action, including the protection of the right to the highest attainable standard of physical and mental health across the life course.
A major moment for this advocacy came on 10 March with the official WHO flagship side event, “No gender equality without women’s health”, co-sponsored by WHO, the United Kingdom of Great Britain and Northern Ireland, United Mexican States, UN Women and the World Economic Forum. The event drew a full house and highlighted a unified call for evidence-based approaches to address gaps in women’s health across the life course as a core component of advancing gender inequality and through health, particularly amid rising anti-rights rhetoric around the world.
A call for holistic, life-course approaches
The event emphasized that women’s health is not a niche concern, but a global issue that must be addressed across the life course. Without universal access to integrated care for all women, the goals associated with the key commitments of the Beijing Platform for Action will remain out of reach.
Speakers pointed out that while women often live longer than men, they experience poorer health due to systemic barriers and lifelong disadvantage. Investing in women’s health is not only critical for gender equality but could also yield major economic gains, with national health systems potentially saving billions each year.
Addressing data gaps
Several speakers at the event emphasized that limited availability, analysis and use of disaggregated sex and gender data continues to hinder progress. The lack of such data contributes to underinvestment and misdiagnosis, in conditions that specifically, differently or disproportionately affect women and particularly in conditions that remain widely underrecognized, such as endometriosis. Closing this gap and ensuring women’s inclusion in clinical trials could not only improve health outcomes but also generate significant global economic savings, estimated at up to US$ 1 trillion annually.
Young people at the forefront of change
Lucy Fagan, WHO Youth Council member representing the UN Major Group for Children and Youth, offered a vital perspective on the role of youth in advancing gender equality and women’s health. “The Beijing agenda was created before many of us were born,” she said. “Progress is slowing, but youth are now part of the conversation. And we’re here to carry it forward.”
Fagan highlighted that youth-led groups are not only active on the ground, but also resilient, continuing to drive momentum for issues such as sexual and reproductive health and rights (SRHR), gender-based violence (GBV) and mental health despite political pressures and reduced funding. As well as stressing the need for more data disaggregated by age and sex, she emphasized that “we’re driving the work forward from the ground up.” Lucy’s remarks served as a reminder that young people are essential actors in safeguarding progress from CSW through to Beijing+30, and that their voices are especially critical to countering rising anti-rights narratives, especially in digital spaces.
Working towards more intersectional solutions
Panellists emphasized the need for intersectional approaches that address systemic discrimination faced by marginalized groups: older women, women in detention, women with disabilities, those living in rural or indigenous communities and many others. It was also emphasized that women make up the majority of the global health workforce as well as taking 80% of health decisions at the household level, a massive yet underleveraged influence in shaping healthier societies.
WHO at CSW69
WHO’s engagement at CSW69 extended beyond this flagship event. Other sessions included:
Closing the gender nutrition gap: a key feminist approach to fight hunger and malnutrition, co-sponsored by Action contre la Faim, FHI360;
Digital solutions for gender equality and SRHR, which explored tech-driven innovations for advancing women’s health, co-sponsored by Norway, Colombia, UNFPA and WHO/HRP;
Bridging the divide: men and boys as allies and agents of change, co-sponsored by MenEngage Alliance, UN Women, OHCHR, WHO, UNFPA, Government of Sweden, Government of Rwanda, Equimundo and others; and
From potential to progress: multisectoral approaches to empower adolescents, co-sponsored by UNICEF, WHO, FCDO, Plan International and BRAC.
These events reinforced WHO’s commitment to a rights-based and evidence-driven agenda for gender equality and women’s health. The takeaway from WHO at CSW69 is clear: investing in women’s health is not optional; it is essential to achieving the 2030 Agenda and reflects our shared values. In a time of global challenges, advancing gender-responsive health systems and policies that uphold women’s rights is more urgent than ever. And the voices of young people like Lucy Fagan, which are grounded in community action and solidarity, are joining the multigenerational charge and reminding us that there is no gender equality without women’s health and well-being.
The weight limit on Bishopthorpe Bridge has been lifted today (Monday 7 April) following repair works.
In recent months a weight limit has been in place on the bridge after highway teams identified the need for long-term repairs to take place.
Repair work on the bridge started in January with a corrugated steel arch being installed by contractor PB construction below Bishopthorpe Bridge to strengthen the bridge and ensure its long-term future.
In the coming weeks further, more cosmetic works will take place on the bridge. This means the cycle path between Appleton Court and Brunswick Nursery will continue to be closed until 13 May, with diversions in place. The diversion route is via The Orchard, Beech Avenue, Maple Avenue, Appleton Road and Copmanthorpe Lane and will be signposted in both directions.
Councillor Kate Ravilious, Executive Member for Transport at City of York Council said;
We appreciate everyone’s patience while we have carried out these essential repairs. We have done all we can to minimise disruption with Appleton Road and the bridge remaining open to pedestrians, cyclists and vehicles. Access has been maintained to businesses at all times too.
“With the weight limit lifted over the next few weeks work will continue around the bridge. We thank people for their understanding while we finish this much needed project.”
Anyone wanting to know about upcoming works in their area can sign up for email alerts for roadworks and disruption in your area. First, you can create an account with One Network. Then sign in to select the location, type and frequency of one.network alerts you want to receive
PM call with Prime Minister Wong of Singapore: 7 April 2025
Prime Minister Keir Starmer spoke to the Prime Minister of Singapore Lawrence Wong today.
The Prime Minister spoke to the Prime Minister of Singapore Lawrence Wong today.
The leaders began by discussing the tariffs announced by the US last week and the impact on the global economy. They both agreed that there can be no winners in a trade war.
The Prime Minister updated Prime Minister Wong on his calls with other international leaders over the weekend, and they both agreed that it is vital likeminded partners work together to maintain global economic stability.
Free and open trade is fundamental, and the leaders agreed to strengthen collaboration between the UK and Singapore through bilateral agreements including the UK-Singapore Strategic Partnership, with ASEAN and through trading blocs such as the Comprehensive and Progressive Trans-Pacific Partnership.
On the wider bilateral relationship, the leaders committed to further collaboration on areas including technology, security and defence in the 60th year of bilateral relations.
They discussed the upcoming deployment of the UK’s Carrier Strike Group to Singapore, and the Prime Minister underlined his commitment to a free and open Indo-Pacific.
[. This grant has grown by $3.4 billion since 2018-19, and although Alberta performed about 20,000 more surgeries this past year than at that time, this is not good enough. Albertans deserve surgical wait times that don’t just marginally improve but meet the medically recommended wait times for every single patient.
With Acute Care Alberta now fully operational, Alberta’s government is implementing reforms to acute care funding through a patient-focused funding (PFF) model, also known as activity-based funding, which pays hospitals based on the services they provide.
“The current global budgeting model has no incentives to increase volume, no accountability and no cost predictability for taxpayers. By switching to an activity-based funding model, our health care system will have built-in incentives to increase volume with high quality, cost predictability for taxpayers and accountability for all providers. This approach will increase transparency, lower wait times and attract more surgeons – helping deliver better health care for all Albertans, when and where they need it.”
Activity-based funding is based on the number and type of patients treated and the complexity of their care, incentivizing efficiency and ensuring that funding is tied to the actual care provided to patients. This funding model improves transparency, ensuring care is delivered at the right time and place as multiple organizations begin providing health services across the province.
“Exploring innovative ways to allocate funding within our health care system will ensure that Albertans receive the care they need, when they need it most. I am excited to see how this new approach will enhance the delivery of health care in Alberta.”
Patient-focused, or activity-based, funding has been successfully implemented in Australia and many European nations, including Sweden and Norway, to address wait times and access to health care services, and is currently used in both British Columbia and Ontario in various ways.
“It is clear that we need a new approach to manage the costs of delivering health care while ensuring Albertans receive the care they expect and deserve. Patient-focused funding will bring greater accountability to how health care dollars are being spent while also providing an incentive for quality care.”
This transition is part of Acute Care Alberta’s mandate to oversee and arrange for the delivery of acute care services such as surgeries, a role that was historically performed by AHS. With Alberta’s government funding more surgeries than ever, setting a record with 304,595 surgeries completed in 2023-24 and with 310,000 surgeries expected to have been completed in 2024-25, it is crucial that funding models evolve to keep pace with the growing demand and complexity of services.
“With AHS transitioning to a hospital-based services provider, it’s time we are bold and begin to explore how to make our health care system more efficient and manage the cost of care on a per patient basis. The transition to a PFF model will align funding with patient care needs, based on actual service demand and patient needs, reflecting the communities they serve.”
“Covenant Health welcomes a patient-focused approach to acute care funding that drives efficiency, accountability and performance while delivering the highest quality of care and services for all Albertans. As a trusted acute care provider, this model better aligns funding with outcomes and supports our unwavering commitment to patients.”
“Patient-focused hospital financing ties funding to activity. Hospitals are paid for the services they deliver. Efficiency may improve and surgical wait times may decrease. Further, hospital managers may be more accountable towards hospital spending patterns. These features ensure that patients receive quality care of the highest value.”
Leadership at Alberta Health and Acute Care Alberta will review relevant research and the experience of other jurisdictions, engage stakeholders and define and customize patient-focused funding in the Alberta context. This working group will also identify and run a pilot to determine where and how this approach can best be applied and implemented this fiscal year.
Final recommendations will be provided to the minister of health later this year, with implementation of patient-focused funding for select procedures across the system in 2026.
Nova Scotia is welcoming the five heads of mission representing Denmark, Finland, Iceland, Norway and Sweden in Canada, who are in Halifax together on a joint diplomatic visit beginning today, April 7.
During the three-day visit, provincial ministers and other officials will meet with the Nordic region diplomats to explore opportunities to strengthen existing trade partnerships and exchange insights on shared priorities.
For the Nordic countries, areas of special interest include the blue economy (sustainable use of ocean resources for economic growth); renewable energy and green solutions; healthcare and life sciences; technology and innovation; and trans-Atlantic security and defence. For Nova Scotia, this includes opportunities to increase its self-reliance and invest in critical minerals, wind resources and the seafood sector.
“We’re thrilled to welcome the ambassadors from the Nordic region to talk about our shared goals and the mutual benefits of working together to protect citizens and strengthen trade opportunities,” said Barbara Adams, Nova Scotia’s Deputy Premier. “Nova Scotia is ready to do business, and we have a lot to offer. We’re excited to share the innovative work happening in Nova Scotia to harness our resources, promote Nova Scotia products and services and so much more.”
Deputy Premier Adams, who is also Nova Scotia’s Minister responsible for Military Relations, will join the heads of mission for a visit at Canadian Forces Base Halifax. The diplomats’ itinerary also includes stops at the Centre for Ocean Ventures and Entrepreneurship in Dartmouth and the NATO DIANA Regional Office for North America in Halifax, as well as meetings with a half dozen provincial ministers.
The officials began their visit today with a luncheon hosted by Lt.-Gov. Mike Savage. They will later participate in a panel discussion at Dalhousie University hosted by the Halifax chapter of the Canadian International Council. The event is open to the public.
Quotes:
“Nova Scotia and the Nordic region hold much in common. Our economies and the lives of our residents are intertwined with the ocean; we are investing significantly in technology and infrastructure to power our increasingly green and digital economies; and we are hotbeds of innovation, advanced research and culture. On behalf of all five Nordic heads of mission, we very much look forward to our first joint visit to Nova Scotia and to deepening our relations as trans-Atlantic partners.” — Hlynur Guðjónsson, Ambassador of Iceland to Canada
Quick Facts:
the Nordic region includes five sovereign states – Denmark, Finland, Iceland, Norway, Sweden – and the self-governing territories of the Faroe Islands, Greenland and Åland
visiting heads of mission include Hanna-Leena Korteniemi, Ambassador of Finland to Canada; Signe Burgstaller, Ambassador of Sweden to Canada; Hlynur Guðjónsson, Ambassador of Iceland to Canada; Nikolaj Harris, Ambassador of Denmark to Canada; Trygve Bendiksby, Head of Mission, Royal Norwegian Embassy in Ottawa
meetings are scheduled with Growth and Development Minister Colton LeBlanc, Addictions and Mental Health Minister Brian Comer, Fisheries and Aquaculture Minister Kent Smith, Cyber Security and Digital Solutions Minister Jill Balser, Natural Resources Minister Tory Rushton and Environment and Climate Change Minister Timothy Halman
as declared in the Nordic Council of Ministers’ Agenda 2030, the Nordic region has a vision to become the most sustainable and integrated region in the world by 2030
the Nordic Council of Ministers is supporting the visit
Additional Resources:
News release – Premier Promotes Nova Scotia in Denmark: https://news.novascotia.ca/en/2025/04/04/premier-promotes-nova-scotia-denmark
More information on the public panel with the heads of mission is available at: https://events.dal.ca/event/4409-jmeucecic-public-panel-conversation-with-the-nordic-amb
Nordic Co-operation – the Nordic Council of Ministers and the Nordic Council: https://www.norden.org/en
Other than cropping, Province of Nova Scotia photos are not to be altered in any way
A small and humble café serving delicious food and superb specialty coffee! If you’re looking for the perfect spot to stop off and enjoy a morning coffee before work, then Barrio is your café. You can even take home their roasted beans or homemade hot sauce!
Kopiku is an Indonesian style café located at the O’Connor shops. Blending Asian and Australian influences together why not try this unique place and try out the coffee. You can also grab some Nasi Goreng, Mee Goreng and much more.
The perfect finish line for those running or walking around the lake. Sit back and enjoy the view, Curio is located next to Blundells Cottage, nestled among the mature, shady trees.
Want vintage charm meets modern flavour? Try Early Editions range of coffees and organic lattes. Grab a quick coffee or relax and enjoy the weekend with your friends.
Looking for a bakery that offers some of Canberra’s best pastries, artisanal bread, and tarts? You need to check out Silo. Renowned for its high-quality food and excellent service, Silo is a popular choice among locals. Stop by for a coffee and a tart, and don’t forget your loaf of bread for the week!
Enjoy Ona coffee and Instagram-worthy food at East Row. Visit their stylish, industrial café for a meal and coffee before work or during lunch. They’re open 7 days and also offer catering.
Looking for a place to sit outdoors with views of lush trees and gardens? The Bakesmith, owned by the former owner of Le Bon Melange, is the ideal spot to enjoy coffee and a delicious French pastry.
Coffee with a Nordic twist? Try Bedst light, bright roasted coffees. They specialise in coffees from the Nordic region but also showcase coffee from all over the world. A worthwhile trip to check out this niche and popular offering.
Need a coffee on the go? Flatheads not only serves up delicious fish and chips, but also a yummy Will & Co coffee.
Grab a coffee, bring your dog and hang out with friends in the small but inviting outdoor area. A popular spot for locals on weekends serving Redbrick coffee.
DOP is a small but mighty coffee shop serving up authentic Italian Street food and artisan coffee. It’s hole in the wall vibe is hard to miss with the lines of people waiting for a cup of their morning brew!
Start your morning feeling superfine! Grab a coffee and specialty toastie on the way to work. Superfine is a popular morning spot known for its friendly staff and good coffee.
Café by day, function space by night, Deakin & Me is a local fave and beloved by all. Grab a coffee and choose a sandwich from the selection in the deli cabinet.
In Canberra’s industrial area and needing a pick-me-up? Pellegrino’s Café is the perfect spot to grab a toastie and takeaway.
Not only does the Cupping Room roast award winning lattes, but they also have a cookbook! Last year this Canberra local café won the Best Flat White in the Wotif awards, so it’s worth trying out.
Living or working in Kingston and want a great coffee, or an even greater strawberry matcha? Good Neighbour offers delicious baked goods and a huge range of iced matcha’s.
B-side is home to a mix of European comfort foods, tasty coffees, and wines for the night. Wander down Lonsdale Street with which a cup of this European coffee blend.
Get your award-winning coffee straight from the source. The Ona Coffee House offers those in Fyshwick specialty coffee and a fresh, seasonal menu for breakfast and lunch.
Want amazing specialty coffees, artisan sourdough, and pastries crafted to perfection? Sonoma is worth getting in early for. Enjoy their range of baked goods and coffees.
After a cosy warm pub vibe for your morning coffee? Edgar’s Inn has an awarding winning outdoor beer garden and beautiful scenery to enjoy.
Enjoy a coffee and some delicious cake at Super Sweet. Their selection of foods is mouthwatering.
Want a rainbow salad bagel with your coffee? Nicky’s has you covered! You can also grab a French toast tiramisu which is made with their Redbrick coffee.
Gungahlin
Escape to France without leaving Canberra! This French patisserie will serve you up a cup of coffee alongside a French treat.
Serving up a house cold brew and many more delicious coffee choices this isn’t one to miss.
This hole in the wall café is proud to deliver local and quality ingredients within their great coffee.
After a café that loves to experiment with flavours and try out new coffee styles? The Usual is always adding new and exciting things to its specials, think Caramello cold brews, Taro lattes and so much more.
Woden, Weston Creek and Molonglo
In Woden for the day and need to grab a coffee? Happy Hub café will serve up great coffee and meals with a smile.
On the outskirts of Canberra and need a local comfortable café? Check out Pitch Black Café for a great community vibe.
Village Café offers a good cuppa with a friendly smile. They make in-house jams, and their menu includes produce from their kitchen garden. Come for fresh, good-quality food and coffee.
Looking for the perfect cup of coffee and a sweet treat? Find Space Kitchen in the Woden precinct nestled amongst office buildings. A busy café offering breakfast and lunch and a range of specialty cakes and sweet treats.
Source: United Kingdom – Executive Government & Departments
Oral statement to Parliament
Gaza: Minister for Middle East statement on detention of two British MPs in Israel
The Minister for the Middle East, Hamish Falconer, has delivered a statement to The House, following the detention of two British MPs in Israel.
Madam Deputy Speaker, over the weekend, two Members of this House – the Member for Earley and Woodley and the Member for Sheffield Central – on a parliamentary delegation to Israel and the Occupied Palestinian Territories were detained and refused entry by the authorities.
They had both been granted entry clearance in advance of travelling to Israel.
On arrival in Tel Aviv at 2.30pm local time, the two Hon Members were held in immigration for six hours. When I spoke to them at 8.30pm, they believed they were to be detained overnight without their mobile phones.
While the situation was ongoing on Saturday night, the Foreign Secretary spoke to his counterpart, the Israeli Foreign Minister and I spoke with the Deputy Foreign Minister and the Israeli Ambassador.
Following that intervention, both were released from detention but their entry was still denied.
Foreign Office officials supported the two MPs and their staff at the airport as soon as they were alerted to the situation.
After a public statement at 10pm from the Israeli Immigration Authority, they were then flown back in the early hours of Sunday morning.
It is my understanding that this is first time a British MP has been barred from entering Israel.
That decision appears to have been taken on the basis of the comments made in this Chamber.
As the Foreign Secretary has made clear, and as I’m sure almost every member of this House will agree, their treatment is unacceptable and it is deeply concerning.
It is no way to treat democratically elected representatives of a close partner nation. We have made this clear at the highest levels in Israel.
I pay tribute to the contributions that both members have made to this place since they were elected.
I know they both believe in a two-state solution. They have our support and solidarity.
The Foreign Secretary spoke to both MPs while they were in Israel and I met with them earlier today. They have behaved with great dignity.
They were part of a delegation visiting humanitarian projects amid the appalling situation in Gaza and a dangerous and deteriorating situation in the Occupied West Bank.
They were going to see for themselves what is taking place in the Occupied Territories and to meet those directly affected by the shocking rise in settler violence.
Such visits are commonplace for MPs from across this House and from all parties.
Indeed, I’m told that more than 161 Members of Parliament have conducted such visits.
They enrich the knowledge and experience of us as legislators and representatives. They create connections with countries, political counterparts and civil society.
Indeed, I note that both organisations – Medical Aid for Palestinians and Council on Arab British Understanding – have supported visits involving Members from all the main political parties – including the benches opposite.
All Members should therefore be worried by what this decision means and the precedent it sets.
So our message to the Israeli government is not just that this is wrong, but that it is counterproductive.
We have warned them that actions like this will only damage the image of the Israeli government in the eyes of Honourable Members across the House.
Mr Speaker, amid this unnecessary and unwelcome decision, the bloodshed continues in Gaza.
The hostages are still held by Hamas. Essential aid is still blocked by Israel. And yet more innocent Palestinians are suffering.
The killing of 15 paramedics and rescue workers in Rafah on March the 23rd was one of the deadliest attacks on humanitarian staff since the war began.
Madam Deputy Speaker, these deaths are an outrage and we must see this incident investigated transparently and those responsible held to account. Our thoughts remain with the victims and their families.
We will not go quiet in our calls for the violence to stop and in our demands for humanitarian workers and civilians to be protected. We urge all parties to return to ceasefire negotiations.
It is clear that this conflict cannot be won by bombs and bullets, but by diplomacy. A ceasefire is the only way we will bring the conflict to an end and return to negotiations for a lasting peace in the region.
This is the only way we can end the needless loss of humanitarian workers striving to alleviate suffering.
And it is the only pathway towards a two-state solution that we all want to see, where Israelis and Palestinians can live in peace and security. I know Honourable Members across this House will continue to work towards that goal.
A senior United Nations official called for renewed action to fortify the international disarmament architecture, as the 2025 session of the Disarmament Commission opened today amid the highest risk of nuclear weapon use since the cold war.
“It is remarkable that we have so quickly forgotten the lessons of the cold war,” said Izumi Nakamitsu, High Representative for Disarmament Affairs, emphasizing the urgent need for action and reaffirming the Commission’s crucial role as a platform for consensus-building and charting a path forward in today’s volatile security landscape.
“At no time since the height of the cold war has the risk of a nuclear weapon being used been so high, and the mechanisms designed to prevent its use so fragile,” she added.
The Disarmament Commission, a subsidiary body of the General Assembly, provides a forum where all Member States can engage in in-depth, consensus-based discussions on key disarmament issues. While it does not negotiate binding agreements, the Commission focuses on developing recommendations aimed at reducing and ultimately eliminating weapons — particularly weapons of mass destruction such as nuclear arms.
Describing the Commission as “a core component of the disarmament machinery”, the High Representative recalled that the forum has agreed to a range of consensus principles, guidelines and recommendations over the years — from the establishment of nuclear-weapon-free zones to confidence-building measures in the field of conventional arms. Most recently, in 2023, the entity reached consensus on recommendations for practically implementing transparency and confidence-building measures in outer space activities.
Amid concerns over “the growing role of nuclear weapons in military doctrines and security policies”, she stated: “We are drifting away from long-standing and effective disarmament and non-proliferation norms and efforts to prevent any use of a nuclear weapon into dangerous and uncharted territory without the guardrails which have helped to stabilize and sustain global security in the past.”
Global Nuclear Stockpiles Stand at Approximately 12,000
As a result of international treaties, she noted, the world’s nuclear stockpiles in 1986 were reduced from more than 70,000 warheads to around 12,000 today.
Calls for Creative, Practical Approaches to Advance Nuclear Disarmament Despite Geopolitical Divisions
Meeting annually, the Commission typically concentrates on two agenda items at a time, allowing for substantive dialogue in both plenary sessions and working groups. This year — the second of a three-year cycle — the organ continues its discussions on formulating recommendations for achieving nuclear disarmament and non-proliferation of nuclear weapons, as well as fostering common understandings related to emerging technologies in the context of international security.
On the first topic, Ms. Nakamitsu urged the Commission to reaffirm the importance of existing disarmament frameworks, especially multilateral treaties such as the Treaty on the Non-Proliferation of Nuclear Weapons. She encouraged creative and practical approaches to finding common ground and advancing nuclear disarmament, despite geopolitical divisions. The Commission should also safeguard past gains while encouraging fresh ideas to reinvigorate global disarmament efforts.
The prevention of nuclear war and the elimination of nuclear weapons are among the most important tasks entrusted to the international community, she stressed, adding: “It will not happen overnight, but it will never happen if steps are not taken now.”
Framework Key for Ensuring Artificial Intelligence, Quantum Computing Advances Benefit Humanity and Not Facilitate Warfare
On the second topic, she noted that rapid advances in artificial intelligence, quantum computing and space-based services — among others — have the potential to greatly benefit humanity and contribute to achieving common objectives. “At the same time”, she warned, “these advances are reshaping warfare in troubling ways.”
With governance mechanisms failing to keep pace with technological innovation and adoption, she stated that this year’s deliberations will be crucial for establishing the framework within which final negotiations will take place next year.
At the outset of its session, the Commission — which runs through 25 April — elected José Pereira (Paraguay) as Chair, along with Mahmud Mohammed Lawal (Nigeria), Amr Essam (Egypt), and Vivica Münkner (Germany) as Vice-Chairs. It also elected Akaki Dvali (Georgia) and Julia Rodriguez (El Salvador) to serve as Chairs of Working Groups I and II, respectively.
SANTIAGO, Chile, April 07, 2025 (GLOBE NEWSWIRE) — You are cordially invited to participate in Banco Santander Chile’s (NYSE: BSAC) conference call-webcast on Thursday, May 8, 2025, at 10.00 AM (EST time) where we will discuss 1Q 2025 financial results. The Bank’s Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Andrés Sansone, Chief Economist. A question and answer session will follow the presentation.
The Management Commentary report will be published on April 30, 2025, before the market opens. The quiet period begins on April 15.
Banco Santander Chile is one of the companies with the highest risk classifications in Latin America with an A2 rating from Moody’s, A- from Standard and Poor’s, A+ from Japan Credit Rating Agency, AA- from HR Ratings and A from KBRA. All our ratings as of the date of this report have a Stable Outlook.
As of December 31, 2024, the Bank has total assets of $68,458,933 million (US$68,865 million), total gross loans (including loans to banks) at amortized cost of $41,323,844 million (US$41,569 million), total deposits of $31,359,234 million (US$31,545 million) and shareholders’ equity of $4,292,440 million (US$4,318 million). The BIS capital ratio was 17.1%, with a core capital ratio of 10.5%. As of December 31, 2024, Santander Chile employs 8,757 people and has 236 branches throughout Chile.
UK-Kenya defence partnership deepened during Defence Secretary visit to Nairobi
Defence Secretary met with Agnes Wanjiru’s family to offer condolences, fulfilling his commitment and making him the first UK Minister to meet with them.
Focus of the visit was meeting Agnes Wanjiru’s family to offer condolences, fulfilling his commitment from July 2024, making him the first UK Minister to meet them, 13 years since her murder.
Defence Secretary becomes first UK Cabinet Minister under the new Government to visit Kenya, reaffirming critical role of defence partnership in maintaining regional peace and security.
Defence Secretary also met the Cabinet Secretary for Defence and British troops, reaffirming the bilateral defence relationship.
Defence Secretary John Healey has met the family of Agnes Wanjiru on a visit to Kenya, who was killed in 2012, becoming the first UK Government Minister to do so.
During the meeting, the Defence Secretary heard the concerns of the family in their pursuit of justice. He expressed his condolences and his determination that the UK support the Kenyan investigation into the case. The meeting, which took place at the British High Commissioner’s Residence in Nairobi, marked the first time a UK Government Minister has met Ms Wanjiru’s family, and comes shortly after the 13th anniversary of her death.
The Defence Secretary’s visit underlines the UK Government’s commitment to transparency in the case of Agnes Wanjiru.
Defence Secretary, John Healey MP, said:
The purpose of my visit to Kenya was to meet Agnes Wanjiru’s family, who have shown unimaginable strength since losing her in the most horrendous circumstances 13 years ago. I reiterated that the UK Government stands with them in their fight for justice.
I welcome the confirmation this afternoon that the case file has been handed over to the Director of Public Prosecutions for a charging decision. This is a really significant step in resolving this case; we will continue to work closely with the Kenyan authorities to push for progress and secure the justice the family deserve.
His visit to Kenya also reaffirmed the vital importance of the UK-Kenya defence partnership, which delivers a broad programme of cooperation in training, education and capability development to counter shared security threats together. The Defence Secretary was also able to see first-hand the UK’s contribution to regional peace and security in East Africa. He met the Nairobi-based British Peace Support Team (Africa) who train Kenyan and regional troops preparing to deploy on peace support operations in Africa.
During the visit, the Defence Secretary also met Cabinet Secretary for Defence Soipan Tuya to discuss their shared ambitions for the future of the UK-Kenya defence partnership. The discussions focused on mutual security interests, the role of British forces training in Kenya, and collaborative efforts to address regional security challenges. As set out in the Plan for Change, national security is the first duty of the government.
On the relationship with Kenya the Defence Secretary said:
Kenya is an anchor state in an unstable region, and the UK relies and looks to Kenya for regional security. We share the same concerns over growing threats in the region. UK forces already train over 1,100 Kenya Defence Forces personnel and reinforce Kenya’s regional role in supporting peace and countering insurgency. I look forward to developing this work in the future.
From Poland and France to the US, rightwing populist parties dominate rural and post-industrial hinterlands while the centrist liberal vote is concentrated in cities. This urban-rural divide is arguably the main political fault line in Europe and North America today.
It appears the backlash against globalised capitalism is strongest when associated with rural conservatism and xenophobia against migrants. But anti-urban populism has not always been – and perhaps isn’t now – a simple reaction against the forces of modernity.
In my new book, The Last Peasant War: Violence and Revolution in Twentieth-Century Eastern Europe, I explore how peasant movements in eastern Europe during the first half of the 20th century often combined deep resentment of cities with aspirations for radical social and economic change. These movements aimed to create a more egalitarian countryside while enhancing its influence and prosperity.
Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.
The first world war was the main catalyst. Warring countries in central and eastern Europe introduced harsh controls of the rural economy to secure food for armies and the urban labour force. Villagers working small plots of land resented these measures and the cities that dictated their terms.
Confronted with shortages at home and death at the front, hundreds of thousands of peasants deserted from the poorly led armies of Austria-Hungary and Russia. In Austria-Hungary, and later in the Russian civil war, scores of thousands of armed peasant deserters banded together to form motley “green” forces based in forests and hilly areas.
These men, along with recently demobilised soldiers, led a wave of bloody violence in many areas of the east European countryside as the old empires disintegrated. Large estates were sacked, officials chased off, and Jewish merchants robbed and humiliated. Peasant crowds often targeted towns as the places that appeared to mastermind and benefit from their exploitation.
In most places, the unrest did not last long. Yet the deserter movements and other forms of rural wartime resistance galvanised interwar agrarian politics – that is, politics concerned with the cultivation and distribution of land – on a scale not seen before or since.
Peasants demanded the breakup and redistribution of large estate land, the end of wars led by parasitic cities, representation of peasants in national governments proportionate to their numbers, and local autonomy.
These were undeniably revolutionary goals. The Russian Bolshevik leader Vladimir Lenin and his followers were forced to revise the mainstream Marxist view of a backward peasantry. His government legalised land seizures by peasants with a 1917 decree before reintroducing the despised wartime economy and later concluding an uneasy truce with the countryside during the 1920s. The war against the Soviet peasantry was finally won during Stalin’s brutal collectivisation drive in the early 1930s.
Many ambitious peasant initiatives remained isolated from each other: village republics sprouted up in parts of the former Habsburg and Romanov empires with the chief aim of redistributing large estate land.
As the new countries of east central Europe consolidated their power, they faced competition from micro-states in parts of Croatia, Slovenia and Poland. Many short-lived republics were reported across Ukraine and European Russia.
More durable were the rural populist parties that became a defining feature of east European politics. From 1919 to 1923, Bulgaria was ruled by the Bulgarian Agrarian National Union under Aleksandar Stamboliyski, who introduced far-reaching reforms to elevate and reward agricultural work before he was murdered in a coup.
In the former Habsburg lands, agrarian politics mushroomed in the aftermath of the first world war, influencing national politics through the end of the second world war. The peasant masses looked to the Polish People’s party, the Croatian Peasant party, and others to lead them forward on a “third way” to modernity, avoiding the pitfalls of both heartless liberalism and tyrannical communism.
Eastern European governments implemented agrarian reform to benefit land-hungry villagers, but it fell short of expectations. Later, the rise of authoritarian regimes across much of the region by the early 1930s forced many peasant movements out of parliamentary politics. Politically marginalised, reeling from the Great Depression, millions of villagers embraced extremist politics, fascism included.
But Hitler’s occupation of much of eastern Europe found little support among them. Large numbers of peasants joined or supported resistance movements, tipping the scales against the axis forces in Yugoslavia. In Poland, the rural populists had their own armed resistance numbering in the hundreds of thousands: the Peasant Battalions.
By around 1950, peasant revolution was extinguished in Europe. Collectivisation in the east and mechanisation across the continent altered the fabric of rural life. Tens of millions left the land for cities, never to return.
The politics they backed in the era of world wars are now a distant memory. At the time, city dwellers looked at them with a mixture of fear and puzzlement. How, they asked, could men like Stamboliyski and Stjepan Radić of the Croatian Peasant party rail against city life while claiming they wanted to make their societies more equal and prosperous?
Then, as now, the world beyond the metropolis nurtured sentiments far more radical than we often assume.
Jakub Beneš has received funding from UKRI’s Arts and Humanities Research Council.
The Minister for Energy has written to the National Energy System Operator (NESO) to advise that government is republishing the connections reform annex of the Clean Power 2030 Action Plan. The update is intended to address a misalignment between solar capacity allocations and the solar pipeline for 2031 to 2035.
This technical update will enable NESO to allocate network capacity to the most well-developed solar projects across transmission and distribution in each region. The overall solar capacity allocation remains as in the original publication.
Source: Government of Ireland – Department of Jobs Enterprise and Innovation
7th April 2025
Enterprise Ireland stands up dedicated team to support exporters, with over 300 one to one meetings now held and a range of grants available
Diversification remains a key government export policy, with 156 out of a total of 190 overseas EI specialist staff based outside of the US, advising Irish SMEs on opportunities and areas for growth
Minister for Enterprise, Tourism and Employment, Peter Burke said:
“My Department has been preparing for tariffs and economic shocks and we are working with our dedicated agency supporting Irish businesses, Enterprise Ireland. We have established a bespoke team which is currently engaging with SMEs, supporting businesses around tariffs and mitigation measures, as well as offering advice and support on diversification measures. One to one meetings have been held with over 300 companies exporting to the US, with further meetings planned. We continue to urge all businesses exporting to the US to engage directly with Enterprise Ireland.
“Enterprise Ireland has 42 overseas offices, with specialist staff in place to grow businesses and explore new opportunities. Market diversification remains a key priority, as it has been for decades, and which has seen significant success. There are 190 overseas market advisers employed by Government through Enterprise Ireland, with 156 of these outside of the US.
“We also have dedicated schemes and grants, including a strategic consultancy grant for expert advice. We have an existing market discovery fund already open which I will top up further when demand is met, and I will be pro-actively engaging with businesses to make them aware of these supports and ensure they are accessed at scale. We have an expansive trade mission programme plan in place. I am conscious that this is an evolving situation which will be closely monitored and Government will not be found wanting when it comes to resourcing and supporting Irish SMEs, which are the backbone of our economy.“
Two people have been jailed for a combined 13 years for laundering more than £6 million, after an investigation by the Metropolitan Police’s economic crime team.
The group used criminal money to purchase vans and lorries in the UK and sold them to Ukraine. The earnings were then converted into cryptocurrency. They exploited the legitimate demand in Ukraine for vehicles as part of their war effort, and the lack of cryptocurrency regulation, to maximise their profit and made millions in just over a year.
Valeriy Popovych, 52, (08.09.1972) of The Avenue, Sudbury‐on‐Thames, and Vitaliy Lutsak, 43, (07.08.1981) of Shortmead Drive, Cheshunt, Hertfordshire, were sentenced at Wood Green Crown Court on Monday, 7 April, following a five-week trial.
Oksana Popovych, 42, (19.03.1983) of The Avenue, Sudbury‐on‐Thames is due to be sentenced on Friday, 30 May at Wood Green Crown Court.
They were all found guilty of transferring criminal property and running an unregistered money service business, following an investigation by the Met.
The criminal enterprise enabled Valeriy and Oksana Popovych and to purchase a second house in South West London for just under £1 million.
Detective Constable Harry Davies, from the Metropolitan Police, who led the investigation, said:
“This was a thorough and complex investigation into an organised crime gang operating internationally, I’d like to thank the dedicated officers and our partners for their work in bringing this group to justice.
“Mr Popovych presented himself as a hardworking, legitimate tradesman and used his reputation within the second-hand lorry market to clean criminal cash. He also callously saw the conflict in Ukraine as a lucrative business opportunity.
“The sentences given to the group today show how committed we are in tackling organised crime groups and the serious risk they pose to our communities.”
The investigation
Valeriy Popovych ran an export business, Sprint Commercial Ltd, purchasing vehicles in the UK from legitimate traders and selling them in Ukraine. His wife, Valeriy Popovych, was also employed by the business.
He would purchase the goods with criminal cash, the money was deposited in Ukraine and converted to cryptocurrency.
Lutsak acted as the money co-ordinator and would send the Popovychs to collect criminal cash from ‘customers’ in the UK. During the investigation officers found more than $14million in cryptocurrency had passed through his “cyrptowallets” stored on his computer.
A part of the laundered cash was controlled by a Russian National called Semen Kuksov, who was convicted on Friday, 27 October 2023 at Southwark Crown Court, under the National Crime Agency’s (NCA) Operation Destabilise.
Kuksov was sentenced to five years and seven months’ imprisonment at Southwark Crown Court on Thursday, 1 February 2024.
The arrests
Acting on intelligence, on Wednesday, 28 June 2023, police stopped a vehicle in Twickenham in which Valeiry Popovych was the passenger. Following a search of the vehicle Met officers found more than £60,000 in cash and arrested him at the scene.
During a further search at his address on Gloucester Road, Feltham, officers recovered £130,000 in cash. This was seized, alongside a laptop and mobile devices.
Following Popovych’s arrest, extensive investigations by the Economic Crime Unit discovered the link with Oksana and Lutsak, who were arrested at their homes on Wednesday, 15 May 2024. Lutsak was charged on the same day.
Valeriy and Oksana Popvych were charged on Tuesday, 14 June 2024.
They were all found guilty by the jury on Wednesday, 5 March 2025 at Wood Green Crown Court.
A variety of complex evidence was obtained by officers, including chats, money transactions, CCTV, cryptocurrency wallets and call logs.
The Met’s economic crime unit worked with partner agencies including the NCA, HM Revenue and Customs and the Financial Conduct Authority to conduct a robust investigation.
Messages outlined key times in which Valeriy and Popovych visited addresses to collect cash.
The most crucial element was an Excel spreadsheet, named ‘V Enf Acc’. This document proved the group laundered over £6 million between August 2022 and June 2023.
Valeriy Popovych and Vitaliy Lutsak were were both sentenced to six years and six months’ imprisonment.
They were all found guilty of transferring criminal property over the value of £6 million under Section 327 of the Proceeds of Crime Act 2002 and running an unregistered money service business under the Money Laundering, Terrorist Financing and Transfer of Funds Regulations 2017.
Negeen Momtahen, Specialist Prosecutor for the Crown Prosecution Service, said:
“Together, these defendants used an export business as a front to launder millions of pounds of criminal cash across borders. They attempted to conceal the source of this illicit money by using secret token exchanges and cryptocurrency.
“Money laundering is not a victimless crime – it is the financial lifeline which enables criminals to profit from their illegal activities.
“Last year we convicted other key members of this same money laundering network. I hope this latest prosecution demonstrates our ongoing determination to dismantling these criminal operations and bringing all involved to justice.
“We will be pursuing confiscation proceedings against the defendants to remove any available criminal benefits gained from this enterprise.”
Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 7 April 2025 – Euronext, the leading European capital market infrastructure, today announced trading volumes for March 2025.
Monthly and historical volume tables are available at this address:
France, Corporate Flavio Bornancin-Tomasella +33 1 70 48 24 45
Ireland Andrea Monzani +39 02 72 42 62 13
Italy Ester Russom +39 02 72 42 67 56
The Netherlands Marianne Aalders +31 20 721 41 33
Norway Cathrine Lorvik Segerlund +47 41 69 59 10
Portugal Sandra Machado +351 91 777 68 97
Corporate Solutions Andrea Monzani +39 02 72 42 62 13
About Euronext
Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway and Portugal.
As of March 2025, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal host nearly 1,800 listed issuers with €6.3 trillion in market capitalisation, a strong blue-chip franchise and the largest global centre for debt and fund listings. With a diverse domestic and international client base, Euronext handles 25% of European lit equity trading. Its products include equities, FX, ETFs, bonds, derivatives, commodities and indices.
This press release is for information purposes only: it is not a recommendation to engage in investment activities and is provided “as is”, without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext. This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is available at www.euronext.com/terms-use.
The Euronext Group processes your personal data in order to provide you with information about Euronext (the “Purpose”). With regard to the processing of this personal data, Euronext will comply with its obligations under Regulation (EU) 2016/679 of the European Parliament and Council of 27 April 2016 (General Data Protection Regulation, “GDPR”), and any applicable national laws, rules and regulations implementing the GDPR, as provided in its privacy statement available at: www.euronext.com/privacy-policy. In accordance with the applicable legislation you have rights with regard to the processing of your personal data: for more information on your rights, please refer to: www.euronext.com/data_subjects_rights_request_information. To make a request regarding the processing of your data or to unsubscribe from this press release service, please use our data subject request form at connect2.euronext.com/form/data-subjects-rights-request or email our Data Protection Officer at dpo@euronext.com.
Source: United Kingdom – Executive Government & Departments
Press release
Joint statement at the 58th Session of the UN Commission on Population and Development
Joint statement on the 58th Session of the UN Commission on Population and Development delivered by Sierra Leone on Monday 7 April 2025, on behalf of Albania, Andorra, Armenia, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Cabo Verde, Cambodia, Chile, Colombia, Costa Rica, Croatia, Cyprus, Czechia, Democratic Republic of the Congo, Denmark, Dominican Republic, Estonia, Eswatini, Finland, France, Georgia, Germany, Greece, Guinea, Honduras, Iceland, Ireland, Israel, Italy, Japan, Latvia, Lebanon, Lesotho, Liberia, Liechtenstein, Lithuania, Luxembourg, Malta, Mexico, Monaco, Mongolia, Montenegro, Morocco, Nepal, Netherlands, New Zealand, North Macedonia, Norway, Panama, Papua New Guinea, Peru, Poland, Portugal, Republic of Korea, Republic of Moldova, Romania, Samoa, San Marino, Serbia, Sierra Leone, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Timor-Leste, Tunisia, Tuvalu, Ukraine, Uruguay, Zambia and the United Kingdom.
We are making this collective statement to emphasise the urgent need for action to achieve Sustainable Development Goal (SDG) 3. Health is a human right and a foundation of sustainable development, driving economic growth, social cohesion, and individual dignity.
Over the past decades, significant progress has been made in many areas of health. We have seen a reduction in maternal and child mortality, expanded access to modern contraceptive methods as well as maternal and newborn medicines and commodities, improvements in adolescent health and education, addressing sexually transmitted diseases including HIV, and a decline in child and early forced marriages. These achievements give us hope for a healthier future.
However, significant challenges persist, and the urgent need for equal access to health services and opportunities for healthy lives remains out of reach for many.
Health inequalities stemming from complex, interrelated factors such as economic disparities, social exclusion, significant financial hardship, discrimination, and unequal access to resources, has a profound impact on individuals and communities. These inequalities manifest in poor health outcomes, lower life expectancy, reduced household income, and weaker national economic growth potential. Income inequality exacerbates vulnerabilities, limiting access to health services in low-income countries and disadvantaged communities. Social disparities rooted in gender, race, age, class, religion, and ethnicity perpetuate stigma, violence, and adverse health determinants.
Economic disparities within and among countries remain significant, impacting the lives of many individuals. Far too many people are unable to access essential health services or are forced to forgo care due to unaffordability. Rising out-of-pocket health costs are pushing millions into poverty, hindering the realisation of Universal Health Coverage. Conflicts and climate change are straining health systems and the health workforce, contributing to stagnating maternal mortality rates, growing mental health challenges, and the inability of health systems to cope with the rise of non-communicable diseases.
Equitable, inclusive, and resilient health systems are essential to ensure healthy lives and promote well-being. It is imperative to prioritize universally accessible, quality, and comprehensive primary healthcare services. Sexual and reproductive health and reproductive rights must enable individuals to make free and informed decisions about their health and their lives. Addressing the social determinants of health – such as poverty, malnutrition, education, water and sanitation, and gender inequality – is critical for achieving inclusive economic growth that strengthens and benefits all of society.
The health and well-being of adolescents and youth also demands greater attention – they require better access to health services, education, and information that enable them to make informed decisions about their lives.
Investing in health, particularly sexual and reproductive health, is not just a matter of well-being, but also a powerful driver of economic growth. UNFPA estimates that allocating an additional $79 billion by 2030 to expand maternal health and family planning services could yield $660 billion in economic benefits by 2050—preventing 400 million unplanned pregnancies, 1 million maternal deaths, 6 million stillbirths, and 4 million newborn deaths, while also enhancing workforce participation and economic productivity (UNFPA, 2022). Similarly, closing the women’s health gap more broadly could further accelerate economic progress, with the World Economic Forum projecting a potential boost of at least $1 trillion annually to the global economy by 2040.
Greater investments in health infrastructure, workforce capacity, and innovative solutions like digital health can improve service delivery and expand access to services. Strengthening and expanding the global health workforce is at the heart of this. We must address health workforce shortages, ensure equitable distribution, enhance training and pay attention to sustainable retention strategies.
It is vital that we, as policymakers, health organizations, and civil society, address disparities within and among countries, ensuring that people in vulnerable situations, including women, children, older persons, migrants, people with disabilities, and those in extreme poverty, have access to quality, comprehensive health services without financial hardship and discrimination. Our role in promoting responsive health systems that cater to the unique needs of at-risk individuals are key to sustainable and inclusive progress.
A healthier population is central to achieving the 2030 Agenda for Sustainable Development. The ICPD’s Programme of Action has guided countries toward inclusive, equitable policies advancing health and gender equality. By strengthening health systems and addressing inequalities, we can work toward a world where all people can live healthy, productive and fulfilling lives.
Source: United Kingdom – Executive Government & Departments 3
News story
AUKUS partnership strengthened with Prime Minister appointing new Special Representative
Sir Stephen Lovegrove appointed as the Prime Minister’s Special Representative on AUKUS.
Britain will maximise the benefits of AUKUS and unlock more opportunities across the historic partnership, following the Prime Minister appointing Sir Stephen Lovegrove as his Special Representative on AUKUS today.
AUKUS is a landmark security and defence partnership between the UK and two of its oldest and closest partners, Australia and the United States. It will enable Australia to field a fleet of nuclear-powered submarines in the Indo Pacific; strengthen the defence industrial bases of both the UK and the US; and accelerate the development and deployment of cutting-edge technologies by all three countries. The AUKUS submarine programme is set to generate 7,000 additional British jobs, supporting the government’s Plan for Change to kickstart economic growth.
Sir Stephen will support the Defence Secretary and the National Security Adviser to drive the AUKUS programme forward. He brings a wealth of experience, having served as National Security Adviser at the time of the AUKUS announcement in 2021, the Prime Minister’s Defence Industrial Adviser, and as the Permanent Secretary at the Ministry of Defence.
Last year, the Prime Minister and Defence Secretary commissioned Sir Stephen to conduct a Review of the UK’s progress against its core commitments under AUKUS, identifying barriers to success, and setting out recommendations on how to unlock further areas of opportunity, both nationally and with the US and Australia. Sir Stephen presented his findings to the Prime Minister and Defence Secretary earlier this year. His report will be shared with US and Australian partners and a public version released in due course.
Defence Secretary, John Healey said:
AUKUS is a historic partnership which reinforces peace and stability across the Euro-Atlantic and Indo-Pacific, and will also provide thousands of highly skilled jobs and investment in communities across the UK. It shows how defence can be an engine for growth across our three nations while keeping us secure at home, and strong abroad.
Sir Stephen is fully committed to ensuring the UK plays a leading role within AUKUS and holds widely respected national security experience.
I am very grateful to him for taking up this appointment and look forward to working closely with him and our partners in the US and Australia as we take the AUKUS partnership to new heights.
Prime Minister’s Special Representative on AUKUS, Sir Stephen Lovegrove, said:
When the AUKUS partnership was announced in 2021 it was regarded, rightly, as the most significant capability collaboration since the Mutual Defence Agreement of 1958.
Since then, the strategic relevance of AUKUS has only increased. It is a uniquely powerful partnership which will develop and deliver cutting-edge capabilities, help to revitalise Britain’s defence industrial base and provide sustained employment for thousands of people across the UK, US and Australia.
I am delighted to accept the role as the Prime Minister’s Special Representative on AUKUS and I look forward to starting work immediately to help maximise the potential of this vital partnership.
Sir Stephen will begin his role as Special Representative tomorrow. He is travelling to Washington DC this week to present his Review findings to the US government and will then travel to Canberra to share findings with the Australian government after the conclusion of the Australian federal election.
The AUKUS partnership is supporting more unified defence and industrial collaboration, better information and technology sharing and greater resilience. The development of SSN-AUKUS and new cutting-edge military technologies under AUKUS Pillar’s One and Two will help grow the UK’s industrial base and improve the enabling environment. It represents a multi-billion-pound investment into UK industry, supporting thousands of new British jobs.
A Médecins Sans Frontières (MSF) medical team has reported six cases of malnutrition among children in the Samos closed controlled access centre (CCAC) in Greece, which houses asylum seekers. This is the first time MSF has identified malnutrition in the facility since we began working there in 2021.
Six children aged six months to six years were diagnosed with severe or moderate acute malnutrition— a life-threatening condition requiring immediate medical intervention to prevent further deterioration. However, paediatric care remains inadequate, not only in the CCAC but across all of Samos island.
Additionally, cash assistance for asylum seekers has been halted since June, leaving families without the means to buy essential, nutritious food for their children.
Refugee families already endure extreme hardships traveling through multiple countries while facing food insecurity and a lack of medical care. Children are especially vulnerable to the cumulative effects of prolonged malnutrition.
The Greek authorities and European Union institutions must ensure a healthy and safe environment for refugee children, including adequate paediatric healthcare. Cash assistance should also be reinstated so that families can afford nutritious food.
You could also be interested in
Syria
Syria: MSF opens emergency room in Daraya
Project Update7 Apr 2025
Gaza-Israel war
MSF mourns the killing of eleventh colleague in Gaza
Statement4 Apr 2025
Democratic Republic of Congo
Civilians and MSF teams trapped by violence in Walikale, DRC
Councillor Susan Brown, Leader of Oxford City Council, said:
“I was deeply concerned to hear about the stabbing in Blackbird Leys over the weekend. My thoughts are with the young person who was injured and with their loved ones at what must be a frightening and painful time.
“I have been in touch with Thames Valley Police and will continue to work closely with them and other partners to understand what happened and how we can respond together.
“Blackbird Leys is a strong and proud community, and I know many people locally will be feeling unsettled. I support the use of the Section 60 order and additional patrols as a short-term measure to help keep residents safe while police continue their investigations.
“I want to reassure residents that the Council is working alongside the police, youth workers and communities to ensure a visible presence and support for young people and families in the area.
“If you have any information that could help the police, please report it to Thames Valley Police or anonymously via Crimestoppers. We must all come together to tackle the causes of violence and keep our communities safe for everyone.”
If you have any information about the incident in Blackbird Leys on 6 April (incident reference 1366), please contact Thames Valley Police by calling 101 or via their website. You can also report anonymously via Crimestoppers.
On 13 February 2025, Baltic Horizon Fund (the “Fund”) disclosed the plan to terminate the Fund’s Swedish Depositary Receipts („SDR“) program and delist the SDR from Nasdaq Stockholm: https://view.news.eu.nasdaq.com/view?id=1342914&lang=en.
Today, the issuer of SDRs, Nordic Issuing AB, has sent a notice of termination to the SDR holders under section 17.1 of the terms and conditions of the SDR-s (Nordic Issuing AB’s General Terms and Conditions for Swedish Depository Receipts regarding fund units in Baltic Horizon Fund, the „Terms“, available on https://www.baltichorizon.com/wp-content/uploads/2022/12/Terms-and-conditions-for-SDR.pdf). Investors are hereby notified that the SDRs will be terminated on 14 October 2025, which is the record date (the “Record Date”) for de-registration of the SDRs from the Euroclear Sweden register.
As a result of the termination, every holder of the SDR must decide before the Record Date if they will sell their SDRs or convert them into the fund units held in Nasdaq CSD by giving respective notice to Nordic Issuing AB. Where no decision has been made by the holder before the Record Date, mandatory conversion will take place, provided that the respective investor has the ability to hold fund units. If the mandatory conversion is technically impossible, the underlying fund units of the remaining SDRs will be sold by Nordic Issuing AB according to section 17.2 of the Terms. Such SDR holder shall be entitled to the sale proceeds following deduction for reasonable costs, fees and taxes.
The timeline for the termination of the SDRs is set out below:
8 October 2025 – Last day of trading in the SDR on Nasdaq Stockholm
14 October 2025 – Record Date in Euroclear Sweden for the de-registration of the SDRs
Following the Record Date, any remaining SDRs will be mandatorily converted into fund units, or, if the conversion is not possible, the underlying fund units represented by SDRs on the Record Date will be sold by Nordic Issuing AB.
In order to convert the SDRs into fund units, an investor holding the SDRs through a nominee account (the nominee-registered holder) should contact their bank, and an investor holding the SDRs directly (the direct-registered holder) should contact Nordic Issuing at info@nordic-issuing.se.
The Fund invites holders of the SDRs to join its investor conference webinar on the delisting, where more information will be provided on the termination and de-listing, scheduled at 14:00 (local Estonian time) on 14 April 2025.
You will be provided with the webinar link and instructions how to join successfully. The webinar will be recorded and available online for everyone at the company’s website on www.baltichorizon.com.
The Fund is a registered contractual public closed-end real estate fund that is managed by Alternative Investment Fund Manager license holder Northern Horizon Capital AS.
Distribution: GlobeNewswire, Nasdaq Tallinn, Nasdaq Stockholm, www.baltichorizon.com
NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 31 MARCH 2025
Regulated Information
Paris, 7 April 2025
Information about the total number of voting rights and shares pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulations.
Societe Generale is a top tier European Bank with around 119,000 employees serving more than 26 million clients in 62 countries across the world. We have been supporting the development of our economies for 160 years, providing our corporate, institutional, and individual clients with a wide array of value-added advisory and financial solutions. Our long-lasting and trusted relationships with the clients, our cutting-edge expertise, our unique innovation, our ESG capabilities and leading franchises are part of our DNA and serve our most essential objective – to deliver sustainable value creation for all our stakeholders.
The Group runs three complementary sets of businesses, embedding ESG offerings for all its clients:
French Retail, Private Banking and Insurance, with leading retail bank SG and insurance franchise, premium private banking services, and the leading digital bank BoursoBank.
Global Banking and Investor Solutions, a top tier wholesale bank offering tailored-made solutions with distinctive global leadership in equity derivatives, structured finance and ESG.
Mobility, International Retail Banking and Financial Services, comprising well-established universal banks (in Czech Republic, Romania and several African countries), Ayvens (the new ALD I LeasePlan brand), a global player in sustainable mobility, as well as specialized financing activities.
Committed to building together with its clients a better and sustainable future, Societe Generale aims to be a leading partner in the environmental transition and sustainability overall. The Group is included in the principal socially responsible investment indices: DJSI (Europe), FTSE4Good (Global and Europe), Bloomberg Gender-Equality Index, Refinitiv Diversity and Inclusion Index, Euronext Vigeo (Europe and Eurozone), STOXX Global ESG Leaders indexes, and the MSCI Low Carbon Leaders Index (World and Europe).
UK Government must “meet the moment” with decisive action.
First Minister John Swinney has called for a new package of support for industry from the UK Government in the face of global economic uncertainty.
As financial markets react to global events, Mr Swinney has called on the Prime Minister and the Chancellor to change their fiscal rules and commit to a package of investment to support business, workers and consumers.
The First Minister said:
“We are currently enduring a time of global financial and economic uncertainty and volatility. But while we are not immune to global trends, we can be confident in the strength of Scotland’s economy
“Indeed, throughout my time in the United States since last week, there has been a clear confidence in Scotland as a place to do business and as a destination for investment.
“However, the global economy is clearly going through a time of upheaval and it is vital that we see strong action to meet the moment, support Scottish industry and ensure workers and consumers are protected.
“My government will continue to do everything in our power to do that, but given where powers over the economy sit, this will require clear, determined and decisive action from the UK Government.
“The old economic orthodoxies of Westminster will not be enough to meet a moment of real global challenge. The UK Government cannot meet this global uncertainty with austerity – we need to see a new approach which provides investment and support for industry as we are seeing in countries like Spain.
“It is now obvious that the era in which the UK Government’s fiscal rules were set is over. The Prime Minister and the Chancellor must accept that new reality, end their outdated commitment to the fiscal rules and deliver serious investment to support industry.
“And in the face of this economic volatility, the last move any serious government would implement is a tax on jobs. The increase in employer’s national insurance contributions was always the wrong move – but the Prime Minister should not risk further economic damage by making it more difficult for business to take on or keep staff. The Chancellor should abandon the national insurance hike immediately.
“The events of the last few days require truly bold action from the Prime Minister. He cannot simply respond to an unprecedented situation by continuing with a plan set in completely different circumstances and which already looks doomed to failure.”
Paula Radcliffe’s Families on Track relay event is returning to Silksworth on Sunday 13 April from 1pm.
Families are being invited to join in this fun family fitness event at Silksworth Sports Complex on the recently refurbished Silksworth Athletics Track. As a group, families need to complete the 8k (8,000 meters) of continuous running loops of various distances from 200m, 400m and 800m. Families can choose any combination of loops but must run a combined total of 8k. These loops are run individually before running the final stretch to the finish line all together.
Each team can be between three to five people, of which at least one must be under 16 and at least one over 18.
The relay event will give the whole family a chance to be active together, no matter their fitness level. This will be the first event to take place on the recently refurbished Silksworth Athletics Track which received £230,000 worth of funding from Everyone Active last November.
The event takes place on a closed running track and will be a safe and fun event. Everyone who completes the event will receive a medal, t-shirt and goodie bag.
After the run, families can extend their day of fun and fitness and participate in a range of rugby skills delivered by Active Sunderland and partners. This will take place on the 3G pitches near the athletics track. Anyone can take part no matter your age or ability and even without any experience of rugby. This is part of a Community Rugby programme delivered in the city in advance of Sunderland hosting the opening game of the Women’s Rugby World Cup on Friday 22 August at the Stadium of Light.
Come along and take part in some rugby themed games and try something new between 2pm and 4pm.
Councillor Beth Jones, Cabinet Member for Communities, Culture and Tourism at Sunderland City Council, said: “It is fantastic to see this event taking place and bringing families together for a fun day of exercise and sport.
“Paula Radcliffe’s Families on Track event is always so popular, it’s great to see it come back on our newly refurbished athletics track. And the free rugby skills sessions following are a good opportunity for residents to learn the sport and try something new ahead of the Women’s Rugby World Cup this summer.
“I’d like to encourage families to come and take part in this brilliant fun family fitness afternoon.”
Ian Bradgate, contract manager for Everyone Active said: “We are really looking forward to welcoming families from the local community to this fantastic event. This is a great opportunity to showcase our state-of-the-art athletics track to people of all ages and abilities, and we encourage everyone to get involved.”
CIUDAD JUÁREZ, Mexico , April 07, 2025 (GLOBE NEWSWIRE) — Miguel Zaragoza Fuentes, founder and president of Grupo Zeta, has played a significant role in developing the energy sector in Mexico and Latin America.
With a long-term business perspective, he has supported strategic projects to improve the distribution of liquefied petroleum gas (LPG) while contributing to regional economic activity and environmental initiatives.
Energy infrastructure with global reach
One of the key milestones in Zaragoza Fuentes’ career has been developing and operating LPG storage and distribution facilities across several countries. Notably, the plant in Escombreras, Spain, stands out as a project approved by environmental authorities, meeting high standards of safety, operational efficiency, and environmental compliance.
At the same time, Grupo Zeta has expanded its operational network in Guatemala, Honduras, Costa Rica, Panama, and El Salvador, contributing to the region’s energy infrastructure. These efforts have improved access to reliable energy while supporting job creation and local economic growth.
Sustainability and innovation as strategic axes
Miguel Zaragoza Fuentes’s management model is based on constant modernization and environmental commitment. The company has incorporated technologies that optimize its operations, such as low-emission transport vehicles and storage systems that minimize gas leaks, aligning itself with international best practices in energy sustainability.
Zeta Gas has also promoted high-impact environmental programs, such as the “Zeta Gas, the Ecological Flame” project, launched in Guatemala in 2014. This initiative seeks to reduce greenhouse gas emissions using LPG as a clean energy alternative.
Social responsibility and community engagement
As part of its broader approach, the company has supported reforestation campaigns in local communities. These initiatives aim to restore deforested areas and promote environmental awareness with residents’ active participation.
“Every project we undertake reflects a clear business philosophy: responsible growth, purposeful technology, and energy serving the collective well-being,” said Miguel Zaragoza Fuentes.
The projects developed under his leadership have delivered tangible results in the energy sector and have been recognized for their innovative approaches and social contributions. Zeta Gas has received awards for adopting clean technologies and is committed to operational efficiency and environmental stewardship.
Contact:
Miguel Zaragoza Fuentes info@miguelzaragozafuentes.com
Under the initiative and decision of the Board of AB Amber Grid (company code 303090867, registered office address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania) (further on Amber Grid, the Company), the Ordinary General Meeting of Shareholders of Amber Grid s convened at the Company’s registered office (address: Laisvės ave. 10, LT-04215 Vilnius, Lithuania) on 30 April 2025, at 10:00 a.m.
The agenda of the Ordinary General Meeting of Shareholders of Amber Grid:
1) To read the independent auditor’s report on the AB „Amber Grid“ 2024 set of financial statements and the AB „Amber Grid“ 2024 Consolidated Management Report
2) On the approval of the AB „Amber Grid“ 2024 consolidated and separate financial statements
3) On the approval of the distribution of AB „Amber Grid“ profits for 2024
4) On the approval of the information on the remuneration for 2024 of AB „Amber Grid“
The beginning of the shareholders’ registration: at 9:30 a.m., on 30 April 2025. The end of the shareholders’ registration: at 9:45 a.m., on 30 April 2025.
The record date of the Ordinary General Meeting of Shareholders: 23 April 2025. The right of participation and voting at the Ordinary General Meeting of Shareholders can be exercised only by the persons who remain shareholders of Amber Grid by the end of the record date of the Ordinary General Meeting of Shareholders.
A person participating at the General Meeting of Shareholders and entitled to vote must provide a document confirming the person’s identity. A person who is not a shareholder shall, in addition to the afore-mentioned document, provide a document confirming his/her right to vote at the General Meeting of Shareholder.
Participation and voting at the General Meeting of Shareholders by electronic means shall not be possible.
On 7 April 2025, the Board of Amber Grid approved the agenda of the Ordinary General Meeting of Shareholders and the draft decisions of the Meeting:
1) To read the independent auditor’s report on the AB „Amber Grid“ 2024 set of financial statements and the AB „Amber Grid“ 2024 Consolidated Management Report.
The draft decision:
“The Board of Directors submits to the General Meeting of Shareholders for information the Consolidated Management Report of AB „Amber Grid“ (attached). The General Meeting of Shareholders should take into account the opinion of the independent auditor’s report to the shareholders of AB „Amber Grid“ when deciding on the approval of the 2024 set of financial statements of AB „Amber Grid“ (enclosed). No resolution of the General Meeting of Shareholders is required.”
2) On the approval of the AB „Amber Grid“ 2024 consolidated and separate financial statements.
The draft decision:
“To approve the 2024 set of financial statements of AB „Amber Grid“”
3) On the approval of the distribution of AB „Amber Grid“ profits for 2024.
The draft decision:
“To approve the distribution of AB „Amber Grid”’s profit for 2024 (attached)”
4) On the approval of the information on the remuneration for 2024 of AB „Amber Grid“.
The draft decision:
“To approve the information on remuneration for 2024 provided by AB „Amber Grid“ as part of the Consolidated Management Report for 2024 (attached)”.
The shareholders may familiarise themselves with the draft resolutions of the General Meeting of Shareholders and other additional materials related to the General Meeting of Shareholders also with the implementation of the shareholders’ rights at the Central Database of Regulated Information www.crib.lt and on the Company’s website www.ambergrid.lt .
The shareholders of Amber Grid, whose shares are entitled to at least 1/20 of the total number of votes, have the right to supplement the agenda for the General Meeting of Shareholders. The proposal to supplement the agenda shall be submitted in writing and sent by registered mail or delivered to the head office of the Company to the address: Laisvės ave. 10, LT-04215 Vilnius (the “Head Office”). The draft resolutions on the proposed issues or, when it is not mandatory to adopt resolutions, explanatory notes on each proposed issue of the agenda of the General Meeting of Shareholders must be presented alongside the proposal. The agenda will be supplemented if the proposal is received not later than by 15 April 2025.
The shareholders entitled to at least 1/20 of the total number of votes have the right, at any time before the General Meeting of Shareholders or during the meeting, to propose in writing new draft resolutions on the items put on the agenda of the General Meeting of Shareholders. Such proposal must be made in writing and submitted to the Company by registered mail or delivered to the Head Office. The proposal submitted during the meeting must be formalized in writing and delivered to the Secretary of the General Meeting of Shareholders.
The shareholders have the right to submit questions to the Company regarding the agenda of the Ordinary General Meeting of Shareholders to be held on 30 April 2025, in advance, but not later than by 24 April 2025. Questions must be formalized in writing and delivered to the Company by registered mail or to the Head Office. The Company will not provide any answer to the question submitted by a shareholder personally to him / her in case relevant information is available on the Company’s website www.ambergrid.lt.
Each shareholder has the right to authorise a natural or legal person to participate and vote on his/her behalf at the General Meeting of Shareholders. The proxy holder of the shareholder must have the document confirming the person’s identity and the Proxy certified in accordance with the procedure established by the laws, which must be delivered to the Head Office not later than before the end of the registration of the attendees of the Ordinary General Meeting of Shareholders. At the Ordinary General Meeting of Shareholders, the proxy holder has the same rights as would be held by the shareholder represented by him/her. The form of the Proxy for the representation at the General Meeting of Shareholders is available on the website of the Company www.ambergrid.lt.
On the issues on the agenda of the General Meeting of Shareholders, the shareholders may vote in writing by filling in a General Ballot Paper. On the shareholder’s request, the Company, not later than 10 days before the day of the General Meeting of Shareholders, will send a General Ballot Paper by registered mail free of charge or submit it in person against signature to the shareholder. The shareholder or his/her proxy holder must undersign the filled in General Ballot Paper. If the General Ballot Paper is signed by a person who is not a shareholder, a document certifying his / her right to vote must be appended to the filled in Ballot Paper. The duly filled General Ballot Paper must be delivered to the Company by registered mail or submitted against signature at the Head Office not later than before the end of registration of the attendees of the Ordinary General Meeting of Shareholders. The form of the General Ballot Paper is available on the website of the Company www.ambergrid.lt.
On the day of convocation of the Ordinary General Meeting of the Shareholders the total number of shares was 178 382 514. All these shares grant a voting right.
Information referred to in Article 262 of the Law on Companies of the Republic of Lithuania will be available on the website of the Company www.ambergrid.lt.
Information about the additions to the agenda, as well as resolutions adopted by the general meeting will also be available on the Central Database of Regulated Information www.crib.lt.
ANNEXES:
Draft profit allocation of Amber Grid AB of 2024.
Consolidated and separate financial statements of Amber Grid AB for 2024 December 31, consolidated annual report, confirmation of responsible persons, independent auditor’s report.
General Ballot Paper.
Proxy Form.
Press release.
More information:
Laura Šebekienė, Head of Communications of Amber Grid, +370 699 61 246, l.sebekiene@ambergrid.lt
Source: United Kingdom – Executive Government & Departments
Two studies published in JAMA Neurology look at diabetes drugs and the risk of dementia and Alzheimer’s.
Comments on both studies:
Prof Atticus Hainsworth, Professor of Cerebrovascular Disease, St George’s, University of London, said:
“These two studies have looked at drug prescribing databases, to assess whether diabetic medications impact on risk of Alzheimer’s, vascular and other dementia types. The findings are intriguing, even though they are somewhat contradictory. But nothing can substitute for a prospective, hypothesis-testing experiment, which in this context means a prospective clinical trial.”
Prof Mark Evans, University Professor of Diabetic Medicine & Honorary Consultant Physician, Institute of Metabolic Science & Department of Medicine, University of Cambridge, said:
Background:
“It is increasingly apparent that there is an association between diabetes and increased risk of dementia. Although it is not clear how this association is mediated (and whether this is to do with elevated blood glucose from diabetes or a broader effect of diabetes for example on the circulation or inflammation pathways), the obvious pragmatic question arising is whether or not treating diabetes with glucose lowering therapies can reduce risk of dementia and importantly whether certain types of glucose lowering therapy are particularly effective.
“Newer glucose lowering treatments used in (type 2) diabetes seem to carry additional health benefits beyond just glucose lowering. For example, treatments that act via signalling at the GLP-1 receptor or by blocking SGLT glucose transporter channels have been shown to carry broader protective effects for the heart and kidneys.
“Some data already exist to suggest that these agents may also have brain-protective effects against the development of dementia. The evidence to date has largely fallen into two different types. Firstly, examining clinical trials of glucose lowering therapies where usually dementia is not the primary focus but in the clinical trials, investigators will document all health changes including a new diagnosis or change in dementia or cognition. Secondly, examining large real-world datasets for the association between diabetes, different types of therapy and a clinical record of dementia.
These two papers:
“These two papers cover each of these areas respectively. Seminer2et al have performed an analysis of clinical trials broadly similar to ones previously reported. They found that glucose-lowering therapies in general were not significantly associated with a reduction in dementia, although when comparing different types of therapy, GLP-1R targeted drugs but not those acting on SGLT channels were associated with a reduction in dementia. There are cautions arising from these data and the authors have acknowledge these appropriately. Overall, the absolute rates of dementia reported in the studies contributing to their analysis were relatively low which thus reduces the ability for this type of analysis to identify differences. There may be a number of reasons for this, for example the clinical trials were not designed to look in detail for possible changes in dementia.
“The other paper from Tang1 et al was a real-world analysis. Consistent with previous data, this did seem to show less dementia in those using either GLP-1R agonists or SGLT2 inhibitors. The authors were aware of the limitations of observational data. In other words, it may be that the type of person receiving these agents was different from the type of person prescribed other glucose lowering therapies. As an example, one obvious potential confounder from their paper was that the groups receiving GLP 1 agonist or SGLT inhibitor therapy were younger than the comparison groups.
General Reflection:
“Overall these papers whet the appetite for two large clinical trials (EVOKE and EVOKE+) that will complete towards the end of this year. These were specifically designed to look at whether semaglutide, a GLP 1 receptor agonist, can reduce progression of Alzheimer’s dementia and may give us a more definitive answer, at least for GLP 1 receptor agonist treatment.”
Prof David Strain, Associate Professor in Cardiometabolic Health, and a clinical geriatrician, University of Exeter, said:
“Living with diabetes is associated with twice the rate of decline towards both vascular and Alzheimer’s Type dementia. Although long-term high blood sugar is recognised to be warm contributor to this, there are many others including genetics, the body’s ability to produce insulin, episodes of low blood sugar (hypoglycaemia) and inflammation. For years, the best way of preventing this was to attempt to keep the sugar in the “goldilocks zone“ that is not too high but not too low.
“GLP-1 receptor antagonists (such as semaglutide and dulaglutide) and SGLT-2 inhibitors (such as dapagliflozin and empagliflozin) have been demonstrated to control the sugar, and also reduce the inflammation (a key driver of Alzheimer’s disease) and reduce vascular risk (a key driver of vascular dementia) more than would be expected by the sugar control alone. It is therefore no surprise that these data show a lower risk of dementia in people who receive them as part of her routine care.
“We must be cautious how we interpret these data though. Firstly, there were very small numbers of events in the randomised control trials and these were not fully validated so there is a possibility that there were many other cases of dementia missed, indeed that patients reported as having Alzheimer’s type dementia may have had other problems. In the database study, we can never be certain of other unmeasured factors that influenced the doctor to prescribe one medication over another. These may also have had an impact on whether a person would progress to dementia or not.
“It is also important to say this is talking about the risk of dementia in people with diabetes. We have recently seen benefit of the GLP-1 RAs for cardiovascular health in people who do not have diabetes, likewise the SGLT 2 inhibitors are regularly used in other conditions. Today’s studies will need to be replicated prospectively, in people with and without diabetes such as the work we are performing at the University of Exeter, to determine if we can help reduce the progression towards dementia in many more people in the country.”
Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of Glasgow, said:
“These two papers on potential for GLP-1RA medicines to lower dementia risk are somewhat encouraging but they are FAR from definitive, given the design of one is observational and the numbers of people with dementia in the trial meta-analyses were incredibly small, leading to limited power. Hence, we need to await the results of ongoing randomised trials in this area before drawing sensible conclusions. There is optimism GLP-1RAs (and related medicines) may lower future dementia risk, however, given they favourably impact multiple diseases (cardiovascular, hypertension, kidney and diabetes) known to increase dementia risk, it might be that it is having a lower risk of stroke /heart disease and diabetes that actually then is linked to a lower risk of dementia. Hopefully, far more robust trial evidence – needed before any clinical implications are drawn – should be forthcoming in the near future.”
Dr Ivan Koychev, Clinical Reader in Neuropsychiatry and Consultant Neuropsychiatrist, Imperial College London and Central North West London NHS Foundation Trust, said:
“Both papers are of good quality. Tang et al is a large epidemiological study; the limitation comes from the fact that such designs limit the ability to draw conclusions about causality. Seminer et al look at clinical trial data where dementia and cognitive effects were not the primary targets of the studies. Therefore, it is possible that some of these effects were missed or over-reported due to the opportunistic nature of the data collection.
“The two studies add to a growing and remarkably consistent body of evidence that GLP1 receptor agonists associate with a reduction in dementia incidence. The Seminer et al paper is significant as it shows that GLP-1 RAs outperform SGLT-2 inhibitors in clinical trial settings. This suggests that the dementia protection effects are not due to glucose control mechanisms. Instead, inflammation and cerebrovascular effects are likely involved. Overall, these data support the urgent exploration of GLP1 RAs as a preventative treatment in people at risk for dementia.”
Prof Tara Spires-Jones, Director of the Centre for Discovery Brain Sciences at the University of Edinburgh, Group Leader in the UK Dementia Research Institute, and President of the British Neuroscience Association said:
“The study by Tang1 and colleagues examined data from over 90,000 people with diabetes to determine whether treatment with two different glucose lowering drugs were associated with risk of developing dementia. Both glucagon-like peptide-1 receptor agonist (GLP-1RAs) and
sodium-glucose cotransporter-2 inhibitor (SGLT2is) drugs were associated with reduced risk of developing dementia over 8 years from starting treatment compared to people taking other glucose lowering treatments. There was no difference in risk between people taking the GLP-1Ras and SGLT2is. This is a strong study that adds to the growing data suggesting that diabetes increases risk for developing dementia.
“The paper from Seminer2 and colleagues examined data from 26 clinical trials to determine whether glucose lowering treatments were associated with developing dementia. They observed that GLP-1Ras but not but not SGLT2is were associated with a reduction in dementia in these trials.
“Together, these data are encouraging for the potential of using GLP-1Ras to lower dementia risk in people with diabetes, but even within these 2 strong studies, there are slightly conflicting results over SGLT2is highlighting the need for further research. It is important to note that these drugs do have side effects and that they are not guaranteed to prevent dementia. The studies had important limitations including a relatively short follow up time. Future work will be important to understand how risk factors like diabetes and obesity increase risk of dementia to develop effective treatments and prevention strategies.”
Dr Emma Anderson, Principal Research Fellow and Associate Professor of Epidemiology in the Division of Psychiatry, UCL, said:
“Regarding the systematic review of glucose lowering therapies2, my comments are as follows:
“These results should be interpreted with caution for several reasons. Firstly, although an effect of GLP-1RAs was identified for all cause dementia, the heterogeneity in the studies included in this analysis was high (meaning that the studies included are not necessarily comparable, undermining the validity of the combined results). There was tentative evidence that this heterogeneity could have been explained, at least in part, by the proportion of women included in these studies.
“Secondly, there was no evidence of an effect of GLP-1RAs with either Alzheimer’s disease or vascular dementia; the two most common causes of dementia. Thus, overall, there is still a question around whether GLP-1RAs would actually reduce dementia risk.
“For the emulated target trial1, my comment is:
“This study should be interpreted with caution, as emulated target trials are as susceptible to confounding by indication bias as traditional observational epidemiology studies. This means that there is a possibility that the results they have observed are actually due to the underlying reason people are prescribed these glucose-lowering medications in the first place, rather than the medication itself. More robust study designs, which overcome this very important limitation, are needed before such conclusions can be made.”
Prof Masud Husain, Professor of Neurology & Cognitive Neuroscience, University of Oxford, said:
“For me, these new retrospective analyses suggest that GLP-1 receptor agonists, particularly semaglutide, might reduce the risk of developing dementia in people with type 2 diabetes. But we need data from prospective trials to provide stronger evidence.
“The wider question of whether such drugs might also be protective against dementia in people who don’t have diabetes is a really intriguing one, and the focus of several ongoing clinical trials.”
Prof Kevin McConway, Emeritus Professor of Applied Statistics, Open University, said:
“I’ll restrict myself to pointing out a few things about these two studies, which may well all be obvious. I’m writing as a statistician and did not spot any important statistical flaws – but I can’t comment on non-statistical aspects.
“Both studies are only in people who already had type 2 diabetes. I believe there’s been wider interest in whether GLP-1 receptor agonist drugs (GLP-1RAs), such as semaglutide (e.g. Ozempic or Wegovy) might reduce dementia risk, in people who are taking them for other reasons than having diabetes. These studies can’t directly tell us anything about that – though the wider context discussed in the linked editorial by Dr Diana Thiara does make some points about the wider context. That editorial is definitely worth reading to make sense of all this, in my view.
“At first sight it might look like a sort of contradiction that one1 of the studies (Tang et al.) found evidence of a decreased risk of certain dementias in people with type 2 diabetes taking either GLP-1RAs or drugs of another class (SGLT2is) used to lower glucose in people with type 2 diabetes, compared to people with type 2 diabetes taking other glucose-lowering drugs, while the other2 study (Seminer et al.) found no evidence that passed the usual statistical criteria that people with type 2 diabetes taking any of GLP-1RAs, SGLT2is, or another drug called pioglitazone did reduce all-cause dementia. It looks as if one is saying that, in people with type 2 diabetes, taking GLP-1RAs and SGLT2is is associated with reduced dementia risk, and the other is saying that it isn’t associated with reduced dementia risk. But there’s no contradiction, for the following reasons:
The Tang study1 has quite a complicated type of study design (target trial emulation), but that’s still a type of observational study and so cannot completely rule out the possibility that the differences it found in dementia risk are actually caused by something other than the drugs being taken. The Seminer study2 is a systematic review and meta-analysis of randomised trials so doesn’t carry the same bias issues about cause and effect.
The comparator (control) treatments were different in the two studies. In the Tang study1, patients taking either GLP-1RAs or SGLT2is were compared with patients taking a different glucose-reducing drug. In the Seminer study2, patients taking the drugs were compared, in each of the RCTs they considered, with patients taking a placebo (that is, something with no active ingredients that otherwise is just like that drug under trial), so not a drug at all.
The two studies were considering different outcome measures. The Tang study1 considered only Alzheimer’s dementia and related dementias. The Seminer study2 included, as its primary outcome, dementia (of any type) or cognitive impairment.
“Therefore the two studies differ in terms of the treatments involved (taking the comparator, control, treatment into account), the type of study design, and the risk of bias. So direct comparison of their findings doesn’t make as much sense as you might think at first. Again, the Thiara editorial makes this all clearer, I think.
“Despite the overall finding of the Seminer2 meta-analysis that the three drug classes that it considered weren’t associated with a reduction in overall risk of dementia or cognitive impairment, on average, compared to controls taking a placebo, they found that GLP-1RAs (considered on their own, leaving out the other drug classes) were associated with a reduction in dementia risk.
“Tang found overall no difference between the risk of Alzheimer disease and related dementias between type 2 diabetes patients taking GLP-1RAs or SGLT2is, but it did find a lower risk in patients taking semaglutide compared to patients taking SGLT2is.
“Though both studies involved large numbers of patients overall, the number of patients who actually had a dementia diagnosis was pretty low, particularly for newer drugs, and the follow-up time was short, given how long it can take for dementias to develop. This is quite a big limitation.”
Dr Richard Oakley, Director of Research and Innovation, Alzheimer’s Society, said:
“Last year, the Lancet Commission in Dementia Prevention, Intervention and Care – funded by Alzheimer’s Society – highlighted diabetes as one of 14 risk factors for dementia.
“Drugs that lower blood glucose are often used as part of diabetes treatment, and research has shown they might also be effective in reducing dementia risk.
“Whilst both of these studies found a link between GLP-1RAs and reduced dementia risk, only one found SGLT2is, another class of diabetes drug, were also associated with a reduced risk. More research is needed to properly understand how diabetes treatments may lower the risk of dementia, by tracking people for longer, especially as they get older.
“Alzheimer’s Society is interested to hear results from ongoing clinical trials of the GLP-1RA drug semaglutide for people with early Alzheimer’s disease, to learn whether these drugs can slow the course of the disease.”
Comments on just the Tang et al study:
Dr Leah Mursaleen, Head of Clinical Research at Alzheimer’s Research UK, said:
“This study1 used health records from nearly 400,000 people who had type 2 diabetes who were taking drugs called SGLT-2 inhibitors and GLP-1RAs to control their condition. These drugs are usually taken to lower blood sugar levels in diabetes. The researchers compared these drugs with other standard medications used to manage diabetes to evaluate the risk of developing dementia.
“People who were taking the SGLT-2 inhibitors or GLP-1RA medications appeared to have a decreased risk of developing dementia compared with those taking other diabetes medicines.
“The results from this study support the growing evidence that GLP-1RA and SGLT-2 inhibitors medicines may be linked with a lower risk of developing dementia. We don’t know yet why these medicines may be protective, and will need more research to understand how they are affecting the brain.
“Clinical trials are already looking at the use of these types of drugs, including the EVOKE study, which is testing semaglutide (Ozempic) as a potential treatment for people with early Alzheimer’s.
“While the findings of this study are interesting, it’s important to consider whether any other factors might be influencing the results such as the severity of type 2 diabetes, health, income, and education.”
1: ‘GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias’ byHuilin Tanget al.was published in JAMA Neurology at 16:00 UK time on Monday 7 April 2025.
DOI: 10.1001/jamaneurol.2025.0353
2: ‘Cardioprotective Glucose-Lowering Agents and Dementia Risk A Systematic Review and Meta-Analysis’ byAllie Semineret al.was published in JAMA Neurology at 16:00 UK time on Monday 7 April 2025.
DOI: 10.1001/jamaneurol.2025.0360
Declared interests
Prof Atticus Hainsworth: “I lead the Vascular Experimental Medicine team within DementiasPlatformUK:
Prof Mark Evans: “I have received personal fees from Medtronic, Ypsomed, Dexcom, Abbott, Novo Nordisk, Eli Lilly, Sanofi, Zucara, Pila Pharma and research support from NovoNordisk, this includes a current PhD student who is funded by Novo Nordisk to examine the mechanisms underpinning the relationship between diabetes/ metabolic disease and dementia but does not include examining the effects of therapies. Abbott, Eli Lilly, Sanofi. The University of Cambridge has received salary support for MLE from the National Health Service in the East of England through the Clinical Academic Reserve.”
Prof David Strain: “I have received speaker fees from AstraZeneca (dapagliflozin) and Novo Nordisk (semaglutide). I lead the UK Stakeholders consensus document for the management of diabetes in older adults which the current UK guidelines are based.”
Prof Naveed Sattar “Has consulted for several companies that make diabetes medicines but also contributed to several lifestyle trials.
“For Novo Nordisk: have consulted for company in advisory boards but not on any of their weight loss drug trial committees; am on steering committee for ZEUS trial but this is not a weight loss trial product but anti-inflammatory. Do not have any shares either for any product in health etc.
“N.S. declares consulting fees and/or speaker honoraria from Abbott Laboratories, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, and Sanofi; and grant support paid to his university from AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics.”
Dr Ivan Koychev: “IK has received speaker fees as well as an investigator initiated grant to explore the effects of semaglutide in people at risk for dementia from Novo Nordisk.”
Prof Tara Spires-Jones: “I have no conflicts with this study but have received payments for consulting, scientific talks, or collaborative research over the past 10 years from AbbVie, Sanofi, Merck, Scottish Brain Sciences, Jay Therapeutics, Cognition Therapeutics, Ono, and Eisai. I am also Charity trustee for the British Neuroscience Association and the Guarantors of Brain and serve as scientific advisor to several charities and non-profit institutions.”
Dr Emma Anderson: “I have no conflicts of interest.”
Prof Masud Husain: “I don’t have any conflicts of interest.”
Prof Kevin McConway: “Previously a Trustee of the SMC and a member of its Advisory Committee.”
Dr Richard Oakley: “No conflicts of interest to declare from Richard or the Society.”
Dr Leah Mursaleen: “Leah has no conflicts of interest to declare.”
The Safer Routes to School scheme near Manor Primary School includes school zone road markings, new signs, speed cushions, dropped kerbs at crossings and waiting/loading restrictions in Ettingshall Road and Foster Avenue.
A review of the location showed 2 collisions involving pedestrians at school drop off and pick up times in the last 3 years.
Councillor Qaiser Azeem, Cabinet Member for Transport and Green City at City of Wolverhampton Council, said: “These measures are in response to calls for action at this location and follow consultation held on the proposals.
“It will improve safety by slowing traffic and ensuring roads near the school are kept free from vehicles parking dangerously.
“Creating a safer environment will encourage more families to walk to school improving healthy lifestyles, cutting carbon emissions and benefitting air quality.”
Work is due to begin on Wednesday 9 April and last about a week. Works prior to the school holidays will be carried out between 9.30am and 2.30pm.
Temporary 3 way traffic signals will be in place on Ettingshall Road on Friday 11 April and 14 April at the Foster Avenue and Nally Drive junctions.
Ettingshall Road will be closed on 15 April between the junctions of Nally Drive and Foster Avenue from 8am to 4.30pm with diversions in place and access to frontages maintained.
Ettingshall Road will also be closed on 16 and 17 April between the same junctions from 8am to 4.30pm with diversions in place and access to frontages maintained.